Inhibrx, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 1.8 million compared to USD 2.19 million a year ago. Net loss was USD 241.36 million compared to USD 145.23 million a year ago.

Basic loss per share from continuing operations was USD 5.12 compared to USD 3.62 a year ago.